DYRK1B and cancer: While the scope of the current study is limited by its utilization of a single cell line as a model system and its focus on changes in cell-autonomous functions, the findings enhance our comprehension of DYRK1B’s role in cancer and underscore the potential of this understudied protein kinase as a cancer drug target.